Hogan William R, Tsui Fu-Chiang, Ivanov Oleg, Gesteland Per H, Grannis Shaun, Overhage J Marc, Robinson J Michael, Wagner Michael M
The RODS Laboratory, Center for Biomedical Informatics, University of Pittsburgh, Pennsylvania, USA.
J Am Med Inform Assoc. 2003 Nov-Dec;10(6):555-62. doi: 10.1197/jamia.M1377. Epub 2003 Aug 4.
To determine whether sales of electrolyte products contain a signal of outbreaks of respiratory and diarrheal disease in children and, if so, how much earlier a signal relative to hospital diagnoses.
Retrospective analysis was conducted of sales of electrolyte products and hospital diagnoses for six urban regions in three states for the period 1998 through 2001.
Presence of signal was ascertained by measuring correlation between electrolyte sales and hospital diagnoses and the temporal relationship that maximized correlation. Earliness was the difference between the date that the exponentially weighted moving average (EWMA) method first detected an outbreak from sales and the date it first detected the outbreak from diagnoses. The coefficient of determination (r2) measured how much variance in earliness resulted from differences in sales' and diagnoses' signal strengths.
The correlation between electrolyte sales and hospital diagnoses was 0.90 (95% CI, 0.87-0.93) at a time offset of 1.7 weeks (95% CI, 0.50-2.9), meaning that sales preceded diagnoses by 1.7 weeks. EWMA with a nine-sigma threshold detected the 18 outbreaks on average 2.4 weeks (95% CI, 0.1-4.8 weeks) earlier from sales than from diagnoses. Twelve outbreaks were first detected from sales, four were first detected from diagnoses, and two were detected simultaneously. Only 26% of variance in earliness was explained by the relative strength of the sales and diagnoses signals (r2 = 0.26).
Sales of electrolyte products contain a signal of outbreaks of respiratory and diarrheal diseases in children and usually are an earlier signal than hospital diagnoses.
确定电解质产品的销售情况是否包含儿童呼吸道和腹泻疾病爆发的信号,如果是,相对于医院诊断,该信号能提前多久出现。
对1998年至2001年期间三个州六个城市地区的电解质产品销售情况和医院诊断进行回顾性分析。
通过测量电解质销售与医院诊断之间的相关性以及使相关性最大化的时间关系来确定信号的存在。提前时间是指指数加权移动平均(EWMA)方法首次从销售中检测到爆发的日期与首次从诊断中检测到爆发的日期之间的差异。决定系数(r2)衡量了销售和诊断信号强度差异导致的提前时间方差有多少。
在时间偏移1.7周(95%可信区间,0.50 - 2.9周)时,电解质销售与医院诊断之间的相关性为0.90(95%可信区间,0.87 - 0.93),这意味着销售比诊断提前1.7周。采用九西格玛阈值的EWMA从销售中检测到18次爆发平均比从诊断中提前2.4周(95%可信区间,0.1 - 4.8周)。12次爆发首先从销售中被检测到,4次首先从诊断中被检测到,2次同时被检测到。销售和诊断信号的相对强度仅解释了提前时间方差的26%(r2 = 0.26)。
电解质产品的销售包含儿童呼吸道和腹泻疾病爆发的信号,并且通常比医院诊断更早发出信号。